Evidence map›Paper›PMID 37904598›Full record

ArticleNucleic acids research2024

BATMAN-TCM 2.0: an enhanced integrative database for known and predicted interactions between traditional Chinese medicine ingredients and target proteins.

Xiangren Kong, Chao Liu, Zuzhen Zhang, Meiqi Cheng, Zhijun Mei, Xiangdong Li, Peng Liu, Lihong Diao, Yajie Ma, Peng Jiang and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
38.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Luteolin fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Xiangren KongState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.ORCID 0009-0005-6872-0367
Chao LiuState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Zuzhen ZhangSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Meiqi ChengCollege of Life Sciences, Hebei University, Baoding 071002, China.ORCID 0009-0001-8404-3408
Zhijun MeiCollege of Life Sciences, Hebei University, Baoding 071002, China.ORCID 0009-0005-8084-2658
Xiangdong LiCollege of Life Sciences, Hebei University, Baoding 071002, China.
Peng LiuCollege of Life Sciences, Hebei University, Baoding 071002, China.
Lihong DiaoSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Yajie MaCollege of Life Sciences, Hebei University, Baoding 071002, China.
Peng JiangBeijing Geneworks Technology Co., Ltd, Beijing 100101, China.
Xiangya KongBeijing Geneworks Technology Co., Ltd, Beijing 100101, China.
Shiyan NieState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Yingzi GuoState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Ze WangState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Xinlei ZhangBeijing Geneworks Technology Co., Ltd, Beijing 100101, China.
Yan WangState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Liujun TangState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Shuzhen GuoSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Zhongyang LiuState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.ORCID 0000-0002-3371-2392
Dong LiState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.ORCID 0000-0002-8680-0468
Beijing Proteome Research Center · CNHebei University · CNAnhui Medical University · CNBeijing University of Chinese Medicine · CN

Funding

National key Research and Development Program of China 2021YFA1301603National Natural Science Foundation of China 32088101
6 · The paper itself

Abstract

Traditional Chinese medicine (TCM) is increasingly recognized and utilized worldwide. However, the complex ingredients of TCM and their interactions with the human body make elucidating molecular mechanisms challenging, which greatly hinders the modernization of TCM. In 2016, we developed BATMAN-TCM 1.0, which is an integrated database of TCM ingredient-target protein interaction (TTI) for pharmacology research. Here, to address the growing need for a higher coverage TTI dataset, and using omics data to screen active TCM ingredients or herbs for complex disease treatment, we updated BATMAN-TCM to version 2.0 (http://bionet.ncpsb.org.cn/batman-tcm/). Using the same protocol as version 1.0, we collected 17 068 known TTIs by manual curation (with a 62.3-fold increase), and predicted ∼2.3 million high-confidence TTIs. In addition, we incorporated three new features into the updated version: (i) it enables simultaneous exploration of the target of TCM ingredient for pharmacology research and TCM ingredients binding to target proteins for drug discovery; (ii) it has significantly expanded TTI coverage; and (iii) the website was redesigned for better user experience and higher speed. We believe that BATMAN-TCM 2.0, as a discovery repository, will contribute to the study of TCM molecular mechanisms and the development of new drugs for complex diseases.

Indexed as

Databases, PharmaceuticalDrugs, Chinese HerbalMedicine, Chinese TraditionalNetwork PharmacologyHumansProteinsDrugs, Chinese HerbalProteins

Identifiers

PMID37904598
PMCPMC10767940
OpenAlexW4388033637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.